CONMED Corporation

NYSE:CNMD

Medical - Devices

Healthcare
$48.01 +0.75%

+$0.24 today

Market cap
$1.43B
Beta
0.92
P/E (TTM)
18.0
EPS (TTM)
$1.79
Dividend yield
1.24%
52W Low $31.84High $56.64

Volume 0.36M

Average 0.45M

CNMD Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

CONMED CorporationNYSE: CNMD

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) declines year over year

Q1 FY2026 weighted avg shares (diluted) of 30.62M shares fell 1.7% year over year, behind the -0.6% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 1.3% from the prior quarter. Over 3 fiscal years it compounded at +1.2% a year.

Context

  • Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -1.7% toward the trailing-twelve-month pace of -0.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
30.62M-1.3% QoQ
Last fiscal yearDec 2025
31.15M+0.1% YoY
LTMMar 2026
30.94M-0.6% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.7%——
1 year+0.1%——
3-year CAGR+1.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
31.15M USD
Year-over-year change
+0.1%
4-year CAGR
-0.8%

Weighted Avg Shares (Diluted) vs competitors

How CNMD compares with its peers on the latest reported figures

  • CNMD's LTM Mar 2026 weighted avg shares (diluted) of 30.94M shares is the 9th highest of the 11 companies compared; the peer median is 87.04M shares.
  • Its year-over-year change of -0.6% is the 9th highest of 11, against a peer median of +1.1%.
  • Over three fiscal years its annual growth of +1.2% compares with a peer median of +2.1%.
CNMD Competitors Peer median
Weighted Avg Shares (Diluted) for CNMD and competitors
Company Period LTM YoY 3-year CAGR
NEOGNeogen CorporationLTM Aug 2026217.73M +0.3%+4.8%
SSIISS Innovations International, Inc.LTM Mar 2026202.43M +12.0%+268.2%
AHCOAdaptHealth Corp.LTM Apr 2026136.37M +0.3%-0.9%
NVCRNovoCure LimitedLTM Mar 2026112.28M +3.5%+2.1%
NTLAIntellia Therapeutics, Inc.LTM Mar 2026110.2M +9.3%+12.1%
INMDInMode Ltd.LTM Mar 202663.88M -16.7%-8.5%
KMTSKestra Medical Technologies, Ltd.LTM Jan 202651.26M +3.5%—
AZTAAzenta, Inc.LTM Sep 202645.19M -1.3%-12.0%
CNMDCONMED CorporationLTM Mar 202630.94M -0.6%+1.2%
ESTAEstablishment Labs Holdings Inc.LTM Sep 202629.95M +1.9%+6.6%
UFPTUFP Technologies, Inc.LTM Jun 20267.79M +0.2%+0.6%
Peer median (excluding CNMD) 87.04M+1.1%+2.1%

Competitors are the stored peer set for CNMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.01B1.05B1.24B1.31B1.37B
Cost of Revenue442.6M474.23M568.5M573.98M649.12M
Gross Profit568.04M571.25M676.25M733.03M725.38M
Gross Margin56.2%54.6%54.3%56.1%52.8%
Research & Development43.57M47.15M52.6M54.43M55.88M
Selling, General & Admin414.75M454.04M503.04M478.28M528.36M
Operating Expenses458.32M501.19M555.64M532.71M584.24M
Depreciation & Amortization70.74M49.76M71.87M71.86M52.34M
EBITDA179.33M7.8M192.48M272.18M154.55M
EBITDA Margin17.7%0.7%15.5%20.8%11.2%
Operating Income109.72M70.05M120.6M200.33M141.13M
Operating Margin10.9%6.7%9.7%15.3%10.3%
Interest Income00000
Interest Expense35.49M28.91M39.78M37.3M31.09M
Other Income / Expenses(36.61M)(140.92M)(39.78M)(37.3M)(70.01M)
Income Before Tax73.11M(70.86M)80.83M163.03M71.12M
Pre-Tax Margin7.2%-6.8%6.5%12.5%5.2%
Income Tax Expense10.56M9.72M16.37M30.61M24.06M
Net Income62.54M(80.58M)64.46M132.42M47.06M
Net Margin6.2%-7.7%5.2%10.1%3.4%
EPS (Basic)2.14(2.68)2.104.291.52
EPS (Diluted)1.94(2.68)2.044.261.51
Weighted Avg Shares29.16M30.04M30.67M30.85M31.04M
Weighted Avg Shares (Diluted)32.22M30.04M31.55M31.11M31.15M

CONMED Corporation

NYSE:CNMD

Intrinsic Alpha fair value

Locked

Current Price

$48.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.